文献速递间质性肺疾病

特发性肺纤维化连续CT分析:视觉特征与预后比较

Serial CT analysis in idiopathic pulmonary fibrosis: comparison of visual features that determine patient outcome.
PubMed 文献 · Thorax · 2020-04-28

研究在两组IPF队列中评估连续CT视觉特征变化对死亡的预测价值,发现除磨玻璃影外各CT变量变化均与死亡相关,牵引性支气管扩张严重度变化可独立于FVC下降预测死亡,并有助于判断边缘性FVC下降的临床意义。

要点

  • 牵引性支气管扩张严重度变化可独立于FVC下降预测IPF患者死亡。
  • 在边缘性FVC下降患者中,该变化比蜂窝影范围变化识别更多恶化者。
  • 牵引性支气管扩张严重度变化观察者间一致性良好。

核心结论

  • 牵引性支气管扩张严重度变化是疾病进展的指标,可帮助判断边缘性FVC下降的临床重要性。

研究设计与样本

  • 两组IPF队列(队列1 n=103,队列2 n=108),由放射科医生对间隔6至24个月的配对容积CT进行评分。

主要发现

  • 单变量分析中,除磨玻璃影外所有CT变量变化在两组队列均预测死亡。
  • 多变量分析校正年龄、性别、抗纤维化药物使用和基线DLCO后,牵引性支气管扩张严重度变化独立于FVC下降预测死亡。
  • 在边缘性FVC下降患者中,牵引性支气管扩张严重度变化独立预测死亡,且比蜂窝影范围变化识别更多恶化患者。

关键数值与推荐

  • CT变量变化采用5分量表评估。
  • 牵引性支气管扩张严重度变化在两组评分者间均显示良好一致性。

临床怎么用

  • 对IPF患者边缘性FVC下降(5.0%-9.9%范围),可结合连续CT评估牵引性支气管扩张严重度变化辅助判断真实疾病进展。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

AIMS: Patients with idiopathic pulmonary fibrosis (IPF) receiving antifibrotic medication and patients with non-IPF fibrosing lung disease often demonstrate rates of annualised forced vital capacity (FVC) decline within the range of measurement variation (5.0%-9.9%). We examined whether change in visual CT variables could help confirm whether marginal FVC declines represented genuine clinical deterioration rather than measurement noise. METHODS: In two IPF cohorts (cohort 1: n=103, cohort 2: n=108), separate pairs of radiologists scored paired volumetric CTs (acquired between 6 and 24 months from baseline). Change in interstitial lung disease, honeycombing, reticulation, ground-glass opacity extents and traction bronchiectasis severity was evaluated using a 5-point scale, with mortality prediction analysed using univariable and multivariable Cox regression analyses. Both IPF populations were then combined to determine whether change in CT variables could predict mortality in patients with marginal FVC declines. RESULTS: On univariate analysis, change in all CT variables except ground-glass opacity predicted mortality in both cohorts. On multivariate analysis adjusted for patient age, gender, antifibrotic use and baseline disease severity (diffusing capacity for carbon monoxide), change in traction bronchiectasis severity predicted mortality independent of FVC decline. Change in traction bronchiectasis severity demonstrated good interobserver agreement among both scorer pairs. Across all study patients with marginal FVC declines, change in traction bronchiectasis severity independently predicted mortality and identified more patients with deterioration than change in honeycombing extent. CONCLUSIONS: Change in traction bronchiectasis severity is a measure of disease progression that could be used to help resolve the clinical importance of marginal FVC declines.

来源:Thorax,查看原文。版权归原作者所有。

引用

  1. Jacob J, Aksman L, Mogulkoc N, et al. Serial CT analysis in idiopathic pulmonary fibrosis: comparison of visual features that determine patient outcome. Thorax. 2020. PMID: 32345689. doi:10.1136/thoraxjnl-2019-213865

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。